News | News By Subject | News by Disease News By Date | Search News

Colorectal cancer News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Chinese Billionaire's Biotech Hutchison China MediTech (Chi-Med) Shows Off Phase III Cancer Drug Data     3/6/2017
Roche (RHHBY)'s Avastin Successor Flunks Key Study, Turns Hope to Tecentriq Instead     10/21/2016
XBiotech (XBIT)'s Colorectal Cancer Drug Claims Fall Apart, Shares Plummet     7/6/2016
Epigenomics AG Receives FDA Approval For Epi proColon     4/13/2016
Incyte (INCY) Plunges on Halted Colorectal Cancer Study     1/29/2016
Amgen (AMGN)'s Vectibix + BSC Meets Primary Endpoint in Phase III Study     1/25/2016
FDA Bestows Merck & Co. (MRK)'s Keytruda with Breakthrough Status to Treat Advanced Colorectal Cancer     11/2/2015
Top 10 Best-Selling Biotech Drugs     10/2/2015
Amgen (AMGN) Brings in More Good News on Phase III Cancer Trial     6/23/2015
AVEO Oncology (AVEO) Tumbles on Disappointing FDA Feedback for Tivozanib     6/15/2015
Eli Lilly (LLY) Snags North American Rights to Erbitux From Bristol-Myers Squibb (BMY)     4/16/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Alchemia (ACL.AX) Shares Plummet On Failed Colorectal Cancer Trial     10/27/2014

News from Around the Web
Vitamin A Compound Retinoic Acid May Help Fight Colorectal Cancer Risk, Stanford University Study     9/2/2016
Can A Dirty Mouth Worsen Colorectal Cancer? Harvard School of Public Health Study     8/12/2016
Two Reasons To Take Aspirin Regularly, One Reason Not To. What Should You Do?     4/13/2016
Coffee Consumption Linked To Decreased Colorectal Cancer Risk, University of Southern California Study     4/4/2016
Regular Aspirin Use Cuts Overall Cancer Risk, Massachusetts General Hospital Study     3/4/2016
Link Revealed Between Obesity And Colorectal Cancer, Thomas Jefferson University Study     1/15/2016
Dead Bacteria Used To Kill Colorectal Cancer, Nanyang Technological University Scientists Reveal     11/10/2015
Could Swallowable Cameras Replace The Colonoscopy?     7/24/2015
Here's How Aspirin Fights Cancer, University of Minnesota Institute Reveals     5/4/2015
Toxic Drug May Help Battle Colorectal Cancer, MD Anderson Cancer Center Study     4/23/2015
Milk Thistle May Stop Colorectal Cancer Stem Cells From Growing Tumors, University of Colorado Study     4/22/2015
Metformin And Vitamin D3 May Prevent Colorectal Cancer, Case Western Reserve University Study     3/24/2015
Eating Resistant Starch May Help Reduce Red Meat Cancer Risk, Flinders University Study     8/5/2014
Aspirin Can Reduce Colorectal Cancer Risks For Those With Specific Gene, Case Western Reserve University Study     4/23/2014
Soy-Based Compound May Reduce Tumor Cell Proliferation in Colorectal Cancer, Mount Sinai Medical Center Study     4/12/2013

Press Releases
Tarrex Biopharma Inc. Announces FDA Acceptance Of IND Application For TX803 To Commence Phase I Clinical Trials In Colorectal Cancer Patients     3/21/2017
Novigenix Signs Distribution Agreement With Dr Risch Medical Laboratory To Access Swiss German Market For Colox, Its Blood Based Colorectal Cancer Test     3/15/2017
XBiotech (XBIT) Reports Affirmative Interim Analysis Of Global Phase III Colorectal Cancer Study     2/27/2017
New Study Assesses The Utility Of Masimo (MASI) PVi Monitoring During Colorectal Surgery     2/27/2017
Experimental Biology and Medicine Release: Targeting Chemokine Signaling To Overcome Radiation Resistance In Colorectal Cancer     2/24/2017
Owlstone Medical Commences 1,400 Patient Clinical Trial For Early Detection Of Colorectal Cancer     2/7/2017
Isofol Medical AB Release: FDA Clears Company’s IND Application To Start Clinical Program Within Colorectal Cancer With Modufolin     1/24/2017
OncoMed (OMED) Release: Company Initiates Enrollment Of Phase Ib Clinical Trial Of Brontictuzumab For The Treatment Of Metastatic Colorectal Cancer Patients     1/20/2017
OncoMed (OMED) Initiates Enrollment Of Phase Ib Clinical Trial Of Anti-DLL4/VEGF Bispecific Antibody As Second-Line Treatment For Metastatic Colorectal Cancer Patients     1/4/2017
Clinical Genomics Pty Ltd Announces The Launch Of Colvera For Colorectal Cancer Recurrence Monitoring     12/20/2016
NOXXON Pharma AG Signs Clinical Immuno-Oncology Collaboration Agreement With Merck & Co. (MRK) To Study Nox-A12 Combined With Keytruda (Pembrolizumab) In Pancreatic And Colorectal Cancer     12/15/2016
Kite Pharma (KITE) Announces Publication Of T-Cell Therapy Targeting Mutant KRAS In Cancer By The NCI In The New England Journal of Medicine     12/12/2016
Sirtex Medical (SRX.AX) Release: NCCN Guidelines Recommend SIR-Spheres Y-90 Resin Microspheres For The Treatment Of Metastatic Colorectal Cancer     12/12/2016
MTTI Announces That Response Of Colorectal Cancer To Treatment Can Be Detected As Early As One Day After A Single Administration Of Drug     12/1/2016
NW Bio (NWBO) Announces Phase II Clinical Trial Program Combining DCVax-L And Pembrolizumab (Keytruda) For Colorectal Cancer     11/17/2016

//-->